Icid 10% (Ophthalmic Solution)
10 ml drop: ৳ 19.22
Medicine Details
| Category | Details |
|---|---|
| Generic | Sulfacetamide sodium |
| Company | Nipa pharmaceuticals ltd |
| Also available as |
Title
- Icid Ophthalmic Solution
Category
- Ophthalmic Medication
- Eye Care
- Antibacterial Drug
Description
- Indicated for treating conjunctivitis and superficial ocular infections
- Bacteriostatic agent with sulfonamides
- Dosage and administration instructions provided
- Incompatible with silver preparations
- Contraindicated in sulfonamide hypersensitivity
- Potential side effects and precautions outlined
- Pregnancy and lactation warnings given
- Storage condition: Below 25°C
Indications
- Treatment of conjunctivitis
- Treatment of superficial ocular infections
- Adjunctive in systemic sulfonamide therapy of trachoma
Mode of Action
- Bacteriostatic effect
- Inhibition of bacterial synthesis of dihydrofolic acid
- Spectrum of activity against susceptible bacterial strains
Dosage and Administration
- Instill one or two drops into the affected eye(s) every two to three hours initially
- Taper dosages based on response
- Usual treatment duration: 7 to 10 days for conjunctivitis and superficial ocular infections
- Two drops every two hours for trachoma
- Topical administration to be accompanied by systemic administration
Interaction
- Incompatibility with silver preparations
Contraindications
- Hypersensitivity to sulfonamides or any preparation ingredient
Side Effects
- Local irritation
- Stinging and burning
- Bacterial and fungal corneal ulcers
- Less commonly reported reactions such as non-specific conjunctivitis and conjunctival hyperemia
- Potential severe reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis
Pregnancy & Lactation
- Pregnancy Category C
- Potential for kernicterus in newborns
- No adequate and well-controlled studies in pregnant women
- Potential fetal harm when administered to pregnant woman
- Potential development of kernicterus in nursing infants
Precautions & Warnings
- Prolonged use may lead to overgrowth of nonsusceptible organisms including fungi
- Bacterial resistance development
- Effectiveness may be reduced by para-aminobenzoic acid in purulent exudates
- Risk of sensitization recurrence and cross-sensitivity
- Discontinuation advice for hypersensitivity signs
Use in Special Populations
- Pediatric use safety and effectiveness not established under two months of age
Therapeutic Class
- Ophthalmic antibacterial drugs
Storage Conditions
- Store below 25°C